CTIF/KIAA0427 anticorps (N-Term)
Aperçu rapide pour CTIF/KIAA0427 anticorps (N-Term) (ABIN633348)
Antigène
Voir toutes CTIF/KIAA0427 (CTIF) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- KIAA0427 antibody was raised against the N terminal of KIAA0427
-
Purification
- Affinity purified
-
Immunogène
- KIAA0427 antibody was raised using the N terminal of KIAA0427 corresponding to a region with amino acids SSCSFSRGRAPPQQNGSKDNSLDMLGTDIWAANTFDSFSGATWDLQPEKL
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
KIAA0427 Blocking Peptide, (ABIN5614328), is also available for use as a blocking control in assays to test for specificity of this KIAA0427 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KIAA0427 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CTIF/KIAA0427 (CTIF) (CBP80/20-Dependent Translation Initiation Factor (CTIF))
-
Autre désignation
- KIAA0427
-
Sujet
- CTIF is a component of the CBP80/CBP20 translation initiation complex that binds cotranscriptionally to the cap end of nascent mRNA. The CBP80/CBP20 complex is involved in a simultaneous editing and translation step that recognises premature termination codons (PTCs) in mRNAs and directs PTC-containing mRNAs toward nonsense-mediated decay.
-
Poids moléculaire
- 67 kDa (MW of target protein)
Antigène
-